Welcome to LookChem.com Sign In|Join Free
  • or
C40H73BrO9Si5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1359948-56-3

Post Buying Request

1359948-56-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1359948-56-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1359948-56-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,9,9,4 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1359948-56:
(9*1)+(8*3)+(7*5)+(6*9)+(5*9)+(4*4)+(3*8)+(2*5)+(1*6)=223
223 % 10 = 3
So 1359948-56-3 is a valid CAS Registry Number.

1359948-56-3Downstream Products

1359948-56-3Relevant academic research and scientific papers

Synthesis and structure-activity relationship of C-phenyl D-glucitol (TP0454614) derivatives as selective sodium-dependent glucose cotransporter 1 (SGLT1) inhibitors

Hamada, Makoto,Kakinuma, Hiroyuki,Kawabe, Kenichi,Kawamura, Madoka,Kimura, Kayo,Kobashi, Yohei,Koretsune, Hiroko,Kuroda, Shoichi,Okumura-Kitajima, Lisa,Shimizu, Yuki,Shiozawa, Fumiyasu,Yamamoto, Koji

, p. 635 - 652 (2020/07/30)

Sodium-glucose cotransporter 1 (SGLT1) is the primary transporter for glucose absorption from the gastrointestinal tract. While C-phenyl D-glucitol derivative SGL5213 has been reported to be a potent intestinal SGLT1 inhibitor for use in the treatment of type 2 diabetes, no SGLT1 selectivity was found in vitro (IC50 29 nM for hSGLT1 and 20 nM for hSGLT2). In this study we found a new method of synthesizing key intermediates 12 by a one-pot three-component condensation reaction and discovered C-phenyl D-glucitol 41j (TP0454614), which has >40-fold SGLT1 selectivity in vitro (IC50 26 nM for hSGLT1 and 1101 nM for hSGLT2). The results of our study have provided new insights into the structure-activity relationships (SARs) of the SGLT1 selectivity of C-glucitol derivatives.

4 -ISOPROPYLPHENYL GLUCITOL COMPOUNDS AS SGLTL INHIBITORS

-

, (2010/09/17)

The present invention provides 4-isopropylphenyl glucitol compounds which have no tendency to accumulate in the body and which inhibit SGLT1 activity to suppress postprandial hyperglycemia (or impaired glucose tolerance) through suppression of glucose absorption in the small intestine, whereby the compounds, for example, can suppress the onset of diabetes and metabolic syndrome or can treat these diseases. A 4-isopropylphenyl glucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: [Chem. 1] wherein R1 represents a hydrogen atom, etc., R2 represents a methyl group, etc., R3 represents a C1-4 alkyl group substituted with an amino group(s), etc., and R4 represents a hydrogen atom, etc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1359948-56-3